Irish Health Repository >
Hospital Research >
Beaumont Hospital >
Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ.
|Files in This Item:|
There are no files associated with this item.
|Title: ||Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ.|
|Affiliation: ||Department of Neuropathology, Beaumont Hospital, Dublin 9, Ireland. email@example.com|
|Citation: ||Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ. 2012, 318 (17):2245-56 Exp. Cell Res.|
|Journal: ||Experimental cell research|
|Issue Date: ||15-Oct-2012 |
|PubMed ID: ||22705586|
|Abstract: ||Developing targeted therapies for high grade gliomas (HGG), the most common primary brain tumor in adults, relies largely on glioma cultures. However, it is unclear if HGG tumorigenic signaling pathways are retained under in-vitro conditions. Using array comparative genomic hybridization and immunohistochemical profiling, we contrasted the epidermal and platelet-derived growth factor receptor (EGFR/PDGFR) in-vitro pathway status of twenty-six primary HGG cultures with the pathway status of their original HGG biopsies. Genomic gains or amplifications were lost during culturing while genomic losses were more likely to be retained. Loss of EGFR amplification was further verified immunohistochemically when EGFR over expression was decreased in the majority of cultures. Conversely, PDGFRα and PDGFRβ were more abundantly expressed in primary cultures than in the original tumor (p<0.05). Despite these genomic and proteomic differences, primary HGG cultures retained key aspects of dysregulated tumorigenic signaling. Both in-vivo and in-vitro the presence of EGFR resulted in downstream activation of P70s6K while reduced downstream activation was associated with the presence of PDGFR and the tumor suppressor, PTEN. The preserved pathway dysregulation make this glioma model suitable for further studies of glioma tumorigenesis, however individual culture related differences must be taken into consideration when testing responsiveness to chemotherapeutic agents.|
Comparative Genomic Hybridization
In Situ Hybridization, Fluorescence
Receptor, Epidermal Growth Factor
Receptor, Platelet-Derived Growth Factor alpha
Receptor, Platelet-Derived Growth Factor beta
Tumor Cells, Cultured
Tumor Markers, Biological
|Appears in Collections: ||Beaumont Hospital|
this identifier to cite or link
to this item:
|Related articles on PubMed|
Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, Zhu YD, Diao Y, Wang AD, Lan Q
2008 Oct 22
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor.
Perrone F, Da Riva L, Orsenigo M, Losa M, Jocollè G, Millefanti C, Pastore E, Gronchi A, Pierotti MA, Pilotti S
Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease.
Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG, Baker SJ
2010 Jun 20
|See all 103 articles|
All Items in LENUS are protected by copyright, with all rights reserved, unless otherwise indicated.